IRIS
ARDIZZONI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.682
AS - Asia 1.367
EU - Europa 1.170
SA - Sud America 184
AF - Africa 73
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.644
CN - Cina 539
SG - Singapore 501
FI - Finlandia 268
SE - Svezia 197
IE - Irlanda 196
IT - Italia 162
BR - Brasile 143
DE - Germania 133
HK - Hong Kong 99
VN - Vietnam 86
TR - Turchia 65
NL - Olanda 47
GB - Regno Unito 44
ZA - Sudafrica 36
FR - Francia 28
IN - India 26
UA - Ucraina 26
CI - Costa d'Avorio 24
CA - Canada 22
PL - Polonia 19
AR - Argentina 16
RU - Federazione Russa 13
BD - Bangladesh 10
MX - Messico 10
EC - Ecuador 8
BE - Belgio 6
CZ - Repubblica Ceca 6
ES - Italia 6
MA - Marocco 6
JP - Giappone 5
LT - Lituania 5
PK - Pakistan 5
UZ - Uzbekistan 5
AT - Austria 4
CO - Colombia 4
ID - Indonesia 4
VE - Venezuela 4
IQ - Iraq 3
PY - Paraguay 3
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IR - Iran 2
JO - Giordania 2
LU - Lussemburgo 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
SA - Arabia Saudita 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
TJ - Tagikistan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.481
Salva come PNG Salva come JPEG
Città #
Singapore 268
Chandler 260
Ashburn 220
Dublin 196
Beijing 140
Dallas 135
Santa Clara 119
Hong Kong 98
Parma 69
New York 67
Nanjing 66
Dearborn 62
Izmir 57
Munich 55
Shanghai 54
Boardman 53
Ann Arbor 39
Jacksonville 36
Los Angeles 36
Princeton 35
Ho Chi Minh City 34
Johannesburg 34
San Mateo 26
Bremen 25
Abidjan 24
Wilmington 24
Kunming 22
Jinan 20
Turku 20
Hanoi 19
Helsinki 19
Tianjin 18
Shenyang 17
São Paulo 17
Buffalo 15
Denver 15
Nanchang 15
Hefei 14
Warsaw 13
Frankfurt am Main 12
Jiaxing 12
Hebei 11
Seattle 11
Columbus 10
Toronto 9
Guangzhou 8
Hangzhou 8
London 8
Marseille 8
Rio Saliceto 8
Leawood 7
Phoenix 7
Poplar 7
Zhengzhou 7
Brooklyn 6
Brussels 6
Chennai 6
Haikou 6
Haiphong 6
Leipzig 6
Norwalk 6
Pune 6
Bexley 5
Chicago 5
Houston 5
Moscow 5
Ottawa 5
The Dalles 5
Tokyo 5
Woodbridge 5
Amsterdam 4
Belo Horizonte 4
Changsha 4
Chengdu 4
City of London 4
Des Moines 4
Fuzhou 4
Mexico City 4
New Delhi 4
Quito 4
Rio de Janeiro 4
San Francisco 4
Stockholm 4
Taizhou 4
Wroclaw 4
Ankara 3
Biên Hòa 3
Council Bluffs 3
Curitiba 3
Da Nang 3
Genoa 3
Hải Dương 3
Ningbo 3
Novo Hamburgo 3
Nuremberg 3
Orem 3
Raleigh 3
Redwood City 3
Rockville 3
Tashkent 3
Totale 2.782
Salva come PNG Salva come JPEG
Nome #
Isolation and characterization of circulating tumor cells in advanced squamous-cell carcinoma of the lung 188
Characterization of gefitinib uptake in NSCLC cell lines 164
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 164
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 162
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer 157
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 156
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 155
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification 148
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 141
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines 141
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 140
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 136
Neoplasie del polmone in Neoplasie del Distretto Toracico 135
Gefitinib metabolism by CYP1A1 affects biological responses in NSCLC cell lines. 134
ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC 133
Aberrant expression of PTEN in squamous lung cancer cells: molecular analysis and impact on the synergistic combination of the targeted therapy with BKM120 and Defactinib 133
Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer 132
Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. 132
Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion 128
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients 128
CT-guided biopsy of pulmonary nodules: Is pulmonary hemorrhage a complication or an advantage? 128
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 125
Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) 123
MYC Amplification as a Potential Mechanism of Primary Resistance to Crizotinib in ALK-Rearranged Non-Small Cell Lung Cancer: A Brief Report 122
INCREASED SOLUBLE AND MEMBRANE-BOUND PD-L1 EXPRESSION IN NSCLC CELL LINES TREATED WITH PEMETREXED 122
Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer 120
Grading the neuroendocrine tumors of the lung: an evidence-based proposal. 114
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib 107
Targeting oncogenic PI3K/Akt/mTOR pathway in squamous cell lung carcinoma 102
Synergistic effect of PI3K and FAK inhibition in squamous lung cancer cells with reduced PTEN level 101
Effect of dual PI3K and FAK inhibition in squamous lung carcinoma with reduced PTEN level 101
Role of cell gefitinib metabolism in the response of NSCLC cell lines to gefitinib. 95
The maintenance of gefitinib inhibits migration and epithelial-mesenchimal transition of Non-small cell lung cancer cell lines that have become resistant after prolonged gefitinib treatment 94
Synergic anti-proliferative effect of gefitinib and RAD001 in non small cell lung cancer cell lines 86
Preclinical study assessing effects of gefitinib continuation after development of gefitinib resistance in NSCLC with activating EGFR mutations 80
Totale 4.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 2 4 6 26 7 42 2
2021/2022120 1 1 1 12 2 0 5 15 9 9 8 57
2022/2023805 70 113 57 63 73 102 5 54 239 0 21 8
2023/2024279 12 21 6 9 24 92 20 18 11 6 14 46
2024/2025953 37 37 51 67 116 92 24 33 144 69 97 186
2025/20261.194 227 175 199 212 308 73 0 0 0 0 0 0
Totale 4.527